This suggests that the CD16neg resident-like NK cells in the prostate may promote the recruitment of tumor antigen cross-presenting cDC1, with potential beneficial anti-tumor effects, as described in melanoma, breast, and colon cancer (Böttcher et al., 2018). The gene discussed is MPPE1; the disease is melanoma.